Chemed Corporation
Market Cap
$5.64B
P/E Ratio
23.21
EPS
$18.31
Dividend Yield
0.54%
52-Week Range
$365.21 — $583.96
Volume
211.19K
Avg Volume
263.86K
Beta
0.48
Get alerted when CHE hits your target price.
Free — enter your email to get started
P/E (TTM)
23.21
Forward P/E
17.70
PEG Ratio
-1.97
P/S (TTM)
2.23
P/B (TTM)
6.82
P/FCF
98.56
EV/EBITDA
64.06x
EV/Sales
—
ROE (TTM)
0.25%
ROA (TTM)
0.17%
ROIC
0.06%
Gross Margin
0.30%
Operating Margin
0.13%
Net Margin
0.10%
Debt/Equity
0.28
Current Ratio
0.85
EPS Growth (YoY)
-0.12%
Revenue Growth (YoY)
+0.07%
EPS Growth (3Y)
+0.06%
EPS Growth (5Y)
+0.10%
Sales Growth (3Y)
+0.04%
Sales Growth (5Y)
+0.05%
EPS Est (This Year)
$24.01
EPS Est (Next Year)
$26.83
Dividend Yield
—
Annual Dividend
$0.60
Payout Ratio
0.13%
Frequency
—
Ex-Dividend Date
2025-11-17
Cash/Share
$1.23
Hold
1 = Strong Buy, 5 = Strong Sell
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
-2000
Outstanding Shares
14.57M
Float
13.90M
Free Float %
95.41%
RSI (14)
51.97
SMA 20
$445.09
SMA 50
$437.59
SMA 200
$455.08
ATR (14)
11.55
Volatility (Week)
0.01%
Volatility (Month)
0.01%
Pattern
—
1 Day
+1.02%
1 Week
+2.89%
1 Month
+2.34%
3 Months
+4.73%
6 Months
+3.04%
1 Year
—
YTD
+7.74%
All-Time High
$623.61
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
NYSE
IPO Date
1973-05-03
Employees
15695
CEO
Kevin J. McNamara
Index Membership
—
Website
https://www.chemed.com
Chemed Corporation (CHE) is a healthcare company in the medical - care facilities industry listed on the NYSE. With a market capitalization of $5.64B, a P/E ratio of 23.21, and a dividend yield of 0.54%, CHE is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare CHE against other stocks using dozens of fundamental and technical filters.
ARDT
Ardent Health Partners, LLC
$9.76
+1.35%
$1.40B
HCSG
Healthcare Services Group, Inc.
$21.41
+0.38%
$1.47B
UHS
Universal Health Services, Inc.
$168.27
+0.18%
$10.53B
MMED
MiniMed Group, Inc. Common Stock
$12.34
+2.66%
$3.47B
THC
Tenet Healthcare Corporation
$177.12
-1.65%
$15.52B
FMS
Fresenius Medical Care AG & Co. KGaA
$22.57
+1.85%
$12.61B
Chemed Corporation (CHE) has a trailing twelve-month (TTM) P/E ratio of 23.21. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Chemed Corporation (CHE) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Chemed Corporation (CHE) has a market capitalization of $5.64 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Hold" rating on Chemed Corporation (CHE) with an average score of 3.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $475.00 implies 11.8% upside from the current price.
Chemed Corporation (CHE) has returned +7.74% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.